Literature DB >> 2698040

Influence of exogenous ATP on blood sugar, serum insulin and serum free fatty acids in short-term experimental hyperthyroid dogs and in euthyroid controls.

A Renauld1, R C Sverdlik.   

Abstract

We studied the influence of ATP administration on blood sugar (BS), serum immunoreactive insulin (IRI) and serum free fatty acid (FFA) responses to glucose-induced hyperglycemia in short-term experimental hyperthyroid (STEH) dogs and in euthyroid controls. Hyperthyroidism was induced by a 10-day s.c. treatment with 100 micrograms/kg body weight 1-thyroxine. Glucose challenge was performed by i.v. infusion (700 mg/kg body weight as a priming dose, followed by 20 mg/kg body weight/min for 60 min). ATP (1 mg/kg body weight/min) was infused for 100 min 40 min before and 60 min during glucose administration). Glucose-induced hyperglycemia was more prolonged in the hyperthyroid group. ATP treatment did not affect the BS profile of controls but raised that of STEH animals. In the normal controls the insulinemic response to hyperglycemia was enhanced during ATP infusion. By contrast, in the STEH dogs insulin levels during glucose infusion was lower than in controls and did not significantly increase when ATP was added. ATP infusion induced a significant elevation of serum FFA, which was more pronounced in hyperthyroid animals with a greater fall during glucose administration and a marked increase during the period of recovery from hyperglycemia. In conclusion, we postulate that short-term hyperthyroidism in dogs may inhibit adenylate cyclase function in pancreatic B-cells and chiefly stimulate the action of cAMP-phosphodiesterase activity, thereby affecting insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2698040     DOI: 10.1007/BF02624641

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  10 in total

1.  COLORIMETRIC DETERMINATION OF FREE FATTY ACIDS IN BIOLOGICAL FLUIDS.

Authors:  K ITAYA; M UI
Journal:  J Lipid Res       Date:  1965-01       Impact factor: 5.922

2.  Actions of aminophylline on the blood sugar, serum insulin and serum free fatty acid responses to glucose in hyperthyroid dogs.

Authors:  A Renauld; R C Sverdlik; R R Rodríguez
Journal:  Horm Metab Res       Date:  1979-03       Impact factor: 2.936

3.  Serum insulin response to glucose infusion in hyperthyroid dogs.

Authors:  A Renauld; L L Andrade; R C Sverdlik; R R Rodríguez
Journal:  Horm Metab Res       Date:  1974-09       Impact factor: 2.936

4.  Studies on the effect of hyperthyroidism on the insulin response to hyperglycemia in the dog.

Authors:  A Renauld; J E Pinto; R C Sverdlik; V G Foglia
Journal:  Horm Metab Res       Date:  1971-07       Impact factor: 2.936

5.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  Blood concentrations of glucose, insulin and free fatty acids in shortly thyroxine-treated dogs: effects of alpha-blockade and isoproterenol.

Authors:  A Renauld; R C Sverdlik; R R Rodriguez
Journal:  Horm Metab Res       Date:  1982-02       Impact factor: 2.936

Review 7.  Mechanism of glucose-induced insulin secretion.

Authors:  C J Hedeskov
Journal:  Physiol Rev       Date:  1980-04       Impact factor: 37.312

8.  Metabolic and endocrine effects of long-term thyroxine treatment.

Authors:  A Renauld; R C Sverdlik; R R Rodriguez
Journal:  Horm Metab Res       Date:  1978-11       Impact factor: 2.936

9.  Experimental hyperthyroidism in dogs. Evaluation and effects on blood sugar, serum insulin and free fatty acids during glibenclamide infusion test.

Authors:  A Renauld; R C Sverdlik; L L Andrade; R R Rodriguez
Journal:  Horm Metab Res       Date:  1975-09       Impact factor: 2.936

10.  Blood sugar, serum insulin and serum free fatty acid responses to slow graded glucose in thyroxine-treated dogs.

Authors:  A Renauld; R C Sverdlik; D Garrido
Journal:  Acta Diabetol Lat       Date:  1980 Jul-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.